期刊文献+

磁共振波谱在血管性痴呆中的应用 被引量:2

Appfication of magnetic resonance spectroscopy in vascular dementia
原文传递
导出
摘要 血管性痴呆(vascular dementia,VaD)是老年人群中最常见的痴呆类型之一,其发病率仅次于阿尔茨海默病。目前,对VaD的诊断主要依据患者的临床表现、神经影像学以及神经心理学量表检查,尚缺乏敏感性和特异性较高的代谢指标。磁共振波谱是一种无创性检测活体组织能量和代谢变化的技术,近年来越来越多地应用于VaD患者,并在VaD的诊断、鉴别诊断以及认知相关性研究方面取得初步成果。 Vascular dementia (VaD) is one of the most common dementia types in the elderly population. Its incidence is only second to Alzheimer's disease. At present, the diagnosis of VaD mainly based on the clinical manifestations, neuroimaging and neuropsychological scales of the patients. It still lacks higher sensitive and specific metabolism indexes. Magnetic resonance spectroscopy is a noninvasive technique for detecting the energy of living tissues and the changes of metabolism. In recent years, it has been more and more used to patients with VaD and has achieved initial results in the diagnosis, differential diagnosis and cognition-related studies of VaD.
作者 曹丽 孙中武
出处 《国际脑血管病杂志》 北大核心 2011年第7期545-548,共4页 International Journal of Cerebrovascular Diseases
关键词 痴呆 血管性 磁共振波谱学 磁共振成像 阿尔茨海默病 认知障碍 Dementia, vascular Magnetic resonance spectroscopy Magnetic resonance knaging Alzheimer disease Cognition disorders
作者简介 通信作者:孙中武,Email:sunzhwu@hotmail.com
  • 相关文献

参考文献27

  • 1O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol, 2003, 2: 89-98.
  • 2van der Graaf M. In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. Eur Biophys J, 2010, 39: 527-540.
  • 3Rockwood K, Wentzel C, Hachinski V, et al. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology, 2000, 54: 447-451.
  • 4Jellinger KA. The pathology of ischemic-vascular dementia: an update. J Neurol So, 2002, 203-204: 153-157.
  • 5Herminghaus S, Frolich L, Gorriz C, et al. Brain metabolism in Alzheimer disease and vascular dementia assessed by in vivo proton magnetic resonance spectroscopy. Psychiatry Res, 2003, 123: 183- 190.
  • 6Watanabe T, Akiguchi I, Yagi H, et al. Proton magnetic resonance spectroscopy and white matter hyperintensities on magnetic resonance imaging in patients with Alzheimer's disease. Ann N Y Acad Sci, 2002, 977: 423-429.
  • 7Stromillo ML, Dotti MT, Battaglini M, et al. Structural and metabolic brain abnormalities in preclinical cerebral autosomal dominant arteriop- athy with subcortical infarcts and leucoencephalopathy. J Neurol Neurosurg Psychiatry, 2009, 80: 41-47.
  • 8Watanabe T,ShiinoA, Aldguchi I. Absolute quantification in proton magaetic resonance spectroscopy is superior to relative ratio to discriminate Alzheirner's disease from Binswanger's disease. Dement Geriatr Cogn Disord, 2008, 26: 89-100.
  • 9Schuff N, Capizzano AA, Du AT, et al. Different patterns of N- acetylaspartate loss in subcortical ischemic vascular dementia and AD. Neurology, 2003, 61: 358-364.
  • 10Capizzano AA, Schuff N, Amend DL, et al. Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and ^1H MR spectroscopy. AJNR Am J Nenroradiol, 2000, 21 : 621-630.

二级参考文献43

  • 1贾建平.重视血管性认知障碍的早期诊断和干预[J].中华神经科杂志,2005,38(1):4-6. 被引量:266
  • 2楼海燕,张敏鸣.血管性痴呆的磁共振检查[J].国外医学(脑血管疾病分册),2005,13(3):206-209. 被引量:5
  • 3李玉华,张忠阳,殷胜利.正常成人和阿尔茨海默病的扣带回后部质子磁共振频谱研究[J].中国医学影像技术,2006,22(1):64-66. 被引量:18
  • 4Atlas SW. Magnetic resonance imaging of the brain and spine. 3rd edition. New York:Philadelphia Lippincott Williams and Wilkins, 2002 : 1189.
  • 5Waldman AD, Rai GS, McConnell JR, et al. Clinical brain proton magnetic resonance spectroscopy for management of Alzheimer's and sub-cortical ischemic vascular dementia in older people. Arch Gerontol Geriatr, 2002, 35: 137-142.
  • 6Vogt BA, Finch DM, Olson CK. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cerebral Cortex, 1992, 2: 435-443.
  • 7Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology, 2001, 56: 592-598.
  • 8Krishnan KR, Charles HC, Doraiswamy PM, et al. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry, 2003, 160 : 2003-2011.
  • 9Kantarci K, Reynolds G, Petersen RC, et al. Proton MR spectroscopy in mild cognitive impairment and Alzheimer' s disease : comparison of 1.5T and 3T. AJNR, 2003, 24:843-849.
  • 10Kantarci K, Smith GE, Ivnik RJ, et al. 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in norm al aging, mild cognitive impairment and Alzheimer' s disease. J Int Neurepsychol Soc, 2002, 8: 934-942.

共引文献32

同被引文献11

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部